Back to my company list

New

Formation Bio

The AI engine Fit Assessment

Beta

The company provides AI-driven technology platforms for drug development, accelerates clinical trial design and management, and acquires/licenses clinical-stage assets to shorten development timelines in pharma.

Blurb

Formation Bio is a drug development company that strives to provide treatments to patients faster by reimagining clinical trials.

HQ Location

New York (United States)

Founded

2013

Employees

51 - 200

Total funding raised

$528.00M

Funding Status

Series D, $372.00M, June 26, 2024

Formation Bio is an AI-native pharma company differentiated by radically more efficient drug development. The company has built proprietary technology platforms to optimize critical aspects of clinical drug development, enabling more efficient trial design, faster trial completion, and higher quality trial data. Formation Bio acquires clinical-stage drugs from pharmaceutical and biotech companies with the goal to develop assets faster, unlocking greater value per program and ultimately accelerate access to new treatments for patients.



2025 CNBC Disruptor 50

2025 Fierce 15 Award

2024 Endpoints 11 Award